Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount ... Novartis’ Sandoz generics arm, and Hikma have tried unsuccessfully to get ...

Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...

a generic version of GlaxoSmithKline's Advair (fluticasone propionate/salmeterol) partnered with Hikma, and other inhaled and non-inhaled products that generate royalty streams. It also gets ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma ... focusing on first-to-market and first-generic opportunities, and in our commercial activities to support our portfolio. We are reiterating ...

Hikma started CohenCare in 2020 with 3 partners after recognizing a significant gap in compassionate home care options in her community. Her desire to create a nurturing environment for those in ...

Any Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can ...

In a court decision filed this week in Washington, D.C., U.S. District Judge Dabney Friedrich rejected Novartis’ position that the FDA’s July approval of MSN’s Entresto generic was unlawful.

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC: 2100 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Read on to find out more ...